← Back to headlines
Indian High Court Rejects Novo Nordisk Plea Against Dr Reddy's Ozempic-like Drug
The Indian High Court has dismissed an appeal by Novo Nordisk seeking to prevent Dr Reddy's Laboratories from manufacturing and exporting an Ozempic-like drug, allowing the Indian firm to proceed.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
